Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$900.6K
13 trades · 6 insiders
Net · 90d
$-900.6K
Insiders on file
43
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Anderman Todd | Chief Legal Officer | 6 | $0 | $224.7K | 2026-10-08 |
| Kaiser Peter | Chief Development Officer | 15 | $0 | $430.4K | 2026-10-02 |
| Heier Jeffrey S. | Director | 30 | $145.3K | $461.6K | 2026-10-02 |
| Notman Donald | See Remarks | 31 | $108.7K | $466.4K | 2026-08-31 |
| Dugel Pravin | See Remarks, Director | 34 | $0 | $3.23M | 2026-08-25 |
| Nayak Sanjay | Chief Strategy Officer | 18 | $0 | $282.0K | 2026-08-24 |
| Robins Jason Shand | Interim CFO | 3 | $0 | $0 | 2026-06-10 |
| Hong Seung Suh | Director | 13 | $0 | $0 | 2026-06-10 |
| Williams Leslie J. | Director | 14 | $19.8K | $0 | 2026-06-10 |
| Warden Charles M | Director, 10% Owner | 41 | $0 | $16.43M | 2026-06-10 |
| Graves Adrienne L | Director | 8 | $0 | $0 | 2026-06-10 |
| LINDSTROM RICHARD L MD | Director | 33 | $775.3K | $143.0K | 2026-06-10 |
| RAINES MERILEE | Director | 11 | $0 | $0 | 2026-06-10 |
| Waheed Nadia | Chief Medical Officer | 12 | $0 | $332.5K | 2026-06-03 |
| Robinson David Wayne | Global CCO | 2 | $0 | $0 | 2026-01-21 |
| Meyers Steve Lawrence | Chief Commercial Officer | 2 | $0 | $0 | 2026-01-02 |
| Saroj Namrata | Chief Business Officer | 3 | $0 | $277.8K | 2026-01-02 |
| SUMMER ROAD LLC | 10% Owner | 34 | $23.36M | $0 | 2024-02-26 |
| Strassburger Philip C. | General Counsel | 11 | $0 | $89.3K | 2024-02-05 |
| Ozden Rabia Gurses | Chief Medical Officer | 13 | $0 | $100.6K | 2024-02-05 |
| Mattessich Antony C. | President and CEO | 20 | $501.0K | $269.6K | 2024-02-05 |
| White Christopher G | Chief Business Officer | 11 | $0 | $78.9K | 2024-02-05 |
| Goldstein Michael H. | President, Ophthalmology & CMO | 9 | $71.6K | $0 | 2022-02-03 |
| PEACOCK BRUCE | Director | 13 | $0 | $0 | 2021-06-18 |
| Kitchen Patricia | Chief Operations Officer | 3 | $0 | $0 | 2021-02-17 |
| Opaleye Management Inc. | 10% Owner | 3 | $137.9K | $0 | 2020-01-02 |
| Sawhney Amarpreet | President and CEO | 31 | $2.35M | $0 | 2019-06-07 |
| Hanley Kevin F. | Sr. VP Technical Operations | 4 | $111.0K | $0 | 2019-01-02 |
| Bollag Daniel M | Sr. VP Reg. Affairs & Quality | 5 | $197.3K | $0 | 2019-01-02 |
| Chadha Jaswinder | Director | 8 | $0 | $0 | 2018-06-14 |
| OSHEA WILLIAM J | Director | 4 | $0 | $0 | 2018-06-14 |
| GARVEY JAMES M | Director | 3 | $0 | $0 | 2017-06-01 |
| Hurley Charles Andrew | Chief Commercial Officer | 2 | $0 | $0 | 2017-01-31 |
| Talamo Jonathan H. | Chief Medical Officer | 2 | $0 | $0 | 2017-01-31 |
| Ankerud Eric | See Remarks | 4 | $13.0K | $0 | 2017-01-31 |
| Fortune James | Chief Operating Officer | 4 | $0 | $162.5K | 2017-01-31 |
| Smith W Bradford | See Remarks | 3 | $0 | $0 | 2017-01-31 |
| Versant Side Fund III, L.P. | 10% Owner | 14 | $0 | $16.43M | 2015-06-15 |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. | 10% Owner | 4 | $0 | $24.62M | 2015-06-10 |
| Polaris Venture Partners Founders' Fund V, L.P. | 10% Owner | 4 | $0 | $14.75M | 2015-02-02 |
| Ascension Health Ventures II, LLC | 10% Owner | 5 | $2.00M | $0 | 2014-07-30 |
| Polaris Venture Partners Entrepreneurs' Fund V, L.P. | 10% Owner | 16 | $0 | $0 | 2014-07-30 |
| SVLSF IV, LLC | 10% Owner | 20 | $9.30M | $0 | 2014-07-30 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Anderman Todd | Chief Legal Officer | S Sale | 2026-10-08 | 2026-10-13 | 11,984 | $7.29 | $87.4K | 140,484 | SEC↗ |
| Kaiser Peter | Chief Development Officer | S Sale | 2026-10-02 | 2026-10-06 | 9,990 | $7.05 | $70.4K | 254,388 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | S Sale | 2026-10-02 | 2026-10-06 | 10,869 | $7.05 | $76.6K | 307,457 | SEC↗ |
| Notman Donald | Chief Operating Officer | S Sale | 2026-08-31 | 2026-09-02 | 1,099 | $10.24 | $11.3K | 366,529 | SEC↗ |
| Notman Donald | Chief Operating Officer | S Sale | 2026-08-31 | 2026-09-02 | 1,099 | $10.24 | $11.3K | 366,529 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2026-08-25 | 2026-08-26 | 50,092 | — | $0 | 0 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2026-08-25 | 2026-08-26 | 50,092 | — | $0 | 744,903 | SEC↗ |
| Dugel Pravin | See Remarks, Director | G Gift | 2026-08-25 | 2026-08-26 | 50,092 | — | $0 | 744,903 | SEC↗ |
| Dugel Pravin | See Remarks, Director | G Gift | 2026-08-25 | 2026-08-26 | 50,092 | — | $0 | 0 | SEC↗ |
| Dugel Pravin | See Remarks | S Sale | 2026-08-24 | 2026-08-26 | 21,649 | $10.77 | $233.2K | 2,525,429 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | S Sale | 2026-08-24 | 2026-08-26 | 3,296 | $10.78 | $35.5K | 318,326 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | S Sale | 2026-08-24 | 2026-08-26 | 1,897 | $10.78 | $20.4K | 326,898 | SEC↗ |
| Kaiser Peter | Chief Development Officer | S Sale | 2026-08-24 | 2026-08-26 | 3,035 | $10.77 | $32.7K | 264,378 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | S Sale | 2026-08-24 | 2026-08-26 | 1,897 | $10.78 | $20.4K | 326,898 | SEC↗ |
| Kaiser Peter | Chief Development Officer | S Sale | 2026-08-24 | 2026-08-26 | 3,035 | $10.77 | $32.7K | 264,378 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | S Sale | 2026-08-24 | 2026-08-26 | 3,296 | $10.78 | $35.5K | 318,326 | SEC↗ |
| Dugel Pravin | See Remarks, Director | S Sale | 2026-08-24 | 2026-08-26 | 21,649 | $10.77 | $233.2K | 2,525,429 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2026-06-16 | 2026-06-18 | 50,092 | — | $0 | 2,547,078 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2026-06-16 | 2026-06-18 | 50,092 | — | $0 | 50,092 | SEC↗ |
| Williams Leslie J. | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 44,000 | — | $0 | 44,000 | SEC↗ |
| RAINES MERILEE | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 44,000 | — | $0 | 44,000 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Hong Seung Suh | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Robins Jason Shand | Chief Financial Officer | A Award deriv | 2026-06-10 | 2026-06-12 | 14,024 | — | $0 | 14,024 | SEC↗ |
| Graves Adrienne L | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Warden Charles M | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Williams Leslie J. | Director | A Award | 2026-06-10 | 2026-06-12 | 14,000 | — | $0 | 65,433 | SEC↗ |
| RAINES MERILEE | Director | A Award | 2026-06-10 | 2026-06-12 | 14,000 | — | $0 | 60,933 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | A Award | 2026-06-10 | 2026-06-12 | 14,000 | — | $0 | 260,933 | SEC↗ |
| Hong Seung Suh | Director | A Award | 2026-06-10 | 2026-06-12 | 14,000 | — | $0 | 60,933 | SEC↗ |
| Robins Jason Shand | Chief Financial Officer | A Award | 2026-06-10 | 2026-06-12 | 15,441 | — | $0 | 68,097 | SEC↗ |
| Graves Adrienne L | Director | A Award | 2026-06-10 | 2026-06-12 | 14,000 | — | $0 | 64,000 | SEC↗ |
| Warden Charles M | Director | A Award | 2026-06-10 | 2026-06-12 | 14,000 | — | $0 | 100,464 | SEC↗ |
| Waheed Nadia | Chief Medical Officer | S Sale | 2026-06-03 | 2026-06-05 | 14,828 | $8.27 | $122.6K | 300,079 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2026-05-28 | 2026-05-28 | 394,696 | — | $0 | 694,811 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2026-05-28 | 2026-05-28 | 394,696 | — | $0 | 0 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | S Sale | 2026-05-26 | 2026-05-28 | 1,858 | $8.20 | $15.2K | 328,795 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | S Sale | 2026-05-26 | 2026-05-28 | 3,018 | $8.20 | $24.7K | 320,350 | SEC↗ |
| Kaiser Peter | Chief Development Officer | S Sale | 2026-05-26 | 2026-05-28 | 2,967 | $8.20 | $24.3K | 266,141 | SEC↗ |
| Dugel Pravin | See Remarks | S Sale | 2026-05-26 | 2026-05-28 | 21,156 | $8.20 | $173.5K | 2,597,170 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2026-04-09 | 2026-04-13 | 394,696 | — | $0 | 2,618,326 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2026-04-09 | 2026-04-13 | 394,696 | — | $0 | 394,696 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | S Sale | 2026-02-23 | 2026-02-25 | 1,759 | $8.28 | $14.6K | 330,653 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | S Sale | 2026-02-23 | 2026-02-25 | 3,057 | $8.28 | $25.3K | 323,368 | SEC↗ |
| Kaiser Peter | Chief Development Officer | S Sale | 2026-02-23 | 2026-02-25 | 2,810 | $8.28 | $23.3K | 269,108 | SEC↗ |
| Dugel Pravin | See Remarks | S Sale | 2026-02-23 | 2026-02-25 | 20,056 | $8.28 | $166.1K | 3,013,022 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | P Buy | 2026-02-20 | 2026-02-24 | 60,229 | $7.66 | $461.4K | 246,933 | SEC↗ |
| Waheed Nadia | Chief Medical Officer | S Sale | 2026-02-20 | 2026-02-24 | 3,510 | $7.74 | $27.2K | 314,907 | SEC↗ |
| Waheed Nadia | Chief Medical Officer | S Sale | 2026-02-12 | 2026-02-17 | 7,863 | $9.04 | $71.1K | 318,417 | SEC↗ |
| Dugel Pravin | See Remarks | S Sale | 2026-02-12 | 2026-02-17 | 124,882 | $9.04 | $1.13M | 3,033,078 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | S Sale | 2026-02-12 | 2026-02-17 | 10,348 | $9.04 | $93.5K | 332,412 | SEC↗ |
| Notman Donald | Chief Operating Officer | S Sale | 2026-02-12 | 2026-02-17 | 11,446 | $9.04 | $103.5K | 366,356 | SEC↗ |
| Notman Donald | Chief Operating Officer | S Sale | 2026-02-04 | 2026-02-04 | 6,035 | $8.54 | $51.5K | 377,802 | SEC↗ |
| Notman Donald | Chief Operating Officer | S Sale | 2026-02-02 | 2026-02-04 | 5,455 | $9.14 | $49.9K | 383,837 | SEC↗ |
| Robinson David Wayne | Global CCO | A Award deriv | 2026-01-21 | 2026-01-26 | 416,000 | — | $0 | 416,000 | SEC↗ |
| Robinson David Wayne | Global CCO | A Award | 2026-01-21 | 2026-01-26 | 136,000 | — | $0 | 136,000 | SEC↗ |
| Robins Jason Shand | Interim CFO | A Award deriv | 2026-01-20 | 2026-01-22 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Notman Donald | See Remarks | A Award deriv | 2026-01-02 | 2026-01-06 | 240,932 | — | $0 | 240,932 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 240,932 | — | $0 | 240,932 | SEC↗ |
| Waheed Nadia | Chief Medical Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 240,932 | — | $0 | 240,932 | SEC↗ |
| Saroj Namrata | Chief Business Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 240,932 | — | $0 | 240,932 | SEC↗ |
| Kaiser Peter | Chief Development Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 240,932 | — | $0 | 240,932 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 197,650 | — | $0 | 197,650 | SEC↗ |
| Meyers Steve Lawrence | Chief Commercial Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 197,650 | — | $0 | 197,650 | SEC↗ |
| Anderman Todd | Chief Legal Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 197,650 | — | $0 | 197,650 | SEC↗ |
| Notman Donald | See Remarks | A Award | 2026-01-02 | 2026-01-06 | 79,112 | — | $0 | 389,292 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | A Award | 2026-01-02 | 2026-01-06 | 79,112 | — | $0 | 326,425 | SEC↗ |
| Waheed Nadia | Chief Medical Officer | A Award | 2026-01-02 | 2026-01-06 | 79,112 | — | $0 | 326,280 | SEC↗ |
| Saroj Namrata | Chief Business Officer | A Award | 2026-01-02 | 2026-01-06 | 79,112 | — | $0 | 254,620 | SEC↗ |
| Kaiser Peter | Chief Development Officer | A Award | 2026-01-02 | 2026-01-06 | 79,112 | — | $0 | 271,918 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | A Award | 2026-01-02 | 2026-01-06 | 64,900 | — | $0 | 342,760 | SEC↗ |
| Meyers Steve Lawrence | Chief Commercial Officer | A Award | 2026-01-02 | 2026-01-06 | 64,900 | — | $0 | 217,628 | SEC↗ |
| Anderman Todd | Chief Legal Officer | A Award | 2026-01-02 | 2026-01-06 | 64,900 | — | $0 | 152,468 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2025-11-26 | 2025-11-26 | 49,754 | — | $0 | 0 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2025-11-26 | 2025-11-26 | 49,754 | — | $0 | 300,115 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | S Sale | 2025-11-24 | 2025-11-26 | 3,469 | $12.04 | $41.8K | 245,940 | SEC↗ |
| Kaiser Peter | Chief Development Officer | S Sale | 2025-11-24 | 2025-11-26 | 3,007 | $12.02 | $36.1K | 191,433 | SEC↗ |
| Dugel Pravin | See Remarks | S Sale | 2025-11-24 | 2025-11-26 | 19,530 | $12.04 | $235.1K | 3,157,960 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | S Sale | 2025-11-24 | 2025-11-26 | 1,878 | $12.04 | $22.6K | 277,860 | SEC↗ |
| Saroj Namrata | Chief Business Officer | S Sale | 2025-11-05 | 2025-11-07 | 25,865 | $10.74 | $277.8K | 174,135 | SEC↗ |
| Anderman Todd | Chief Legal Officer | S Sale | 2025-10-08 | 2025-10-10 | 11,132 | $12.34 | $137.4K | 87,568 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | S Sale | 2025-10-02 | 2025-10-06 | 10,502 | $11.04 | $115.9K | 249,409 | SEC↗ |
| Kaiser Peter | Chief Development Officer | S Sale | 2025-10-02 | 2025-10-06 | 9,653 | $11.03 | $106.5K | 194,440 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2025-09-09 | 2025-09-11 | 49,754 | — | $0 | 49,754 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2025-09-09 | 2025-09-11 | 49,754 | — | $0 | 3,177,490 | SEC↗ |
| Notman Donald | See Remarks | S Sale | 2025-09-02 | 2025-09-04 | 1,066 | $12.43 | $13.3K | 308,807 | SEC↗ |
| Dugel Pravin | See Remarks | S Sale | 2025-08-25 | 2025-08-27 | 21,494 | $12.04 | $258.8K | 3,227,244 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | S Sale | 2025-08-25 | 2025-08-27 | 3,063 | $12.04 | $36.9K | 259,911 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | S Sale | 2025-08-25 | 2025-08-27 | 1,885 | $12.04 | $22.7K | 279,738 | SEC↗ |
| Kaiser Peter | Chief Development Officer | S Sale | 2025-08-25 | 2025-08-27 | 3,011 | $12.04 | $36.3K | 204,093 | SEC↗ |
| Waheed Nadia | Chief Medical Officer | A Award deriv | 2025-08-12 | 2025-08-14 | 122,923 | — | $0 | 122,923 | SEC↗ |
| Waheed Nadia | Chief Medical Officer | A Award | 2025-08-12 | 2025-08-14 | 40,363 | — | $0 | 247,168 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2025-08-11 | 2025-08-13 | 250,361 | — | $0 | 250,361 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2025-06-12 | 2025-08-13 | 50,029 | — | $0 | 3,248,738 | SEC↗ |
| Graves Adrienne L | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Warden Charles M | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Williams Leslie J. | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 44,000 | — | $0 | 44,000 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 44,000 | — | $0 | 44,000 | SEC↗ |
| RAINES MERILEE | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Hong Seung Suh | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Dugel Pravin | See Remarks | A Award deriv | 2025-06-11 | 2025-06-13 | 2,750,000 | — | $0 | 2,750,000 | SEC↗ |
| Graves Adrienne L | Director | A Award | 2025-06-11 | 2025-06-13 | 14,000 | — | $0 | 50,000 | SEC↗ |
| Warden Charles M | Director | A Award | 2025-06-11 | 2025-06-13 | 14,000 | — | $0 | 86,464 | SEC↗ |
| Williams Leslie J. | Director | A Award | 2025-06-11 | 2025-06-13 | 14,000 | — | $0 | 51,433 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | A Award | 2025-06-11 | 2025-06-13 | 14,000 | — | $0 | 143,145 | SEC↗ |
| RAINES MERILEE | Director | A Award | 2025-06-11 | 2025-06-13 | 14,000 | — | $0 | 46,933 | SEC↗ |
| Hong Seung Suh | Director | A Award | 2025-06-11 | 2025-06-13 | 14,000 | — | $0 | 46,933 | SEC↗ |
| Waheed Nadia | Chief Medical Officer | S Sale | 2025-06-02 | 2025-06-03 | 13,861 | $8.05 | $111.6K | 206,805 | SEC↗ |
| Dugel Pravin | See Remarks | S Sale | 2025-05-23 | 2025-05-27 | 21,219 | $7.18 | $152.4K | 3,499,099 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | S Sale | 2025-05-23 | 2025-05-27 | 3,024 | $7.18 | $21.7K | 262,974 | SEC↗ |
| Kaiser Peter | Chief Development Officer | S Sale | 2025-05-23 | 2025-05-27 | 2,974 | $7.17 | $21.3K | 207,104 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | S Sale | 2025-05-23 | 2025-05-27 | 1,862 | $7.17 | $13.4K | 281,623 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | P Buy | 2025-05-08 | 2025-05-12 | 10,000 | $6.96 | $69.6K | 172,704 | SEC↗ |
| Dugel Pravin | See Remarks | G Gift | 2025-04-28 | 2025-08-13 | 200,332 | — | $0 | 3,298,767 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | S Sale | 2025-02-24 | 2025-02-26 | 1,895 | $6.84 | $13.0K | 283,485 | SEC↗ |
| Kaiser Peter | Chief Development Officer | S Sale | 2025-02-24 | 2025-02-26 | 3,009 | $6.87 | $20.7K | 210,078 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | S Sale | 2025-02-24 | 2025-02-26 | 3,061 | $6.87 | $21.0K | 265,998 | SEC↗ |
| Dugel Pravin | See Remarks | S Sale | 2025-02-24 | 2025-02-26 | 21,475 | $6.87 | $147.5K | 3,520,318 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | A Award deriv | 2025-02-11 | 2025-02-13 | 334,000 | — | $0 | 334,000 | SEC↗ |
| Notman Donald | See Remarks | A Award deriv | 2025-02-11 | 2025-02-13 | 344,115 | — | $0 | 344,115 | SEC↗ |
| Waheed Nadia | Chief Medical Officer | A Award deriv | 2025-02-11 | 2025-02-13 | 237,000 | — | $0 | 237,000 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | A Award | 2025-02-11 | 2025-02-13 | 111,000 | — | $0 | 285,380 | SEC↗ |
| Notman Donald | See Remarks | A Award | 2025-02-11 | 2025-02-13 | 115,000 | — | $0 | 308,444 | SEC↗ |
| Waheed Nadia | Chief Medical Officer | A Award | 2025-02-11 | 2025-02-13 | 79,000 | — | $0 | 220,666 | SEC↗ |
| Dugel Pravin | See Remarks | A Award | 2025-02-11 | 2025-02-13 | 1,250,000 | — | $0 | 2,041,793 | SEC↗ |
| Dugel Pravin | See Remarks | A Award | 2025-02-11 | 2025-02-13 | 1,500,000 | — | $0 | 3,541,793 | SEC↗ |
| Notman Donald | See Remarks | S Sale | 2025-02-04 | 2025-02-04 | 11,119 | $7.81 | $86.8K | 193,444 | SEC↗ |
| Notman Donald | See Remarks | S Sale | 2025-01-31 | 2025-02-04 | 6,301 | $7.84 | $49.4K | 204,563 | SEC↗ |
| Dugel Pravin | See Remarks | S Sale | 2024-11-25 | 2024-11-27 | 20,680 | $9.01 | $186.3K | 791,793 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | S Sale | 2024-11-25 | 2024-11-27 | 1,814 | $9.00 | $16.3K | 174,380 | SEC↗ |
| Kaiser Peter | Chief Development Officer | S Sale | 2024-11-25 | 2024-11-27 | 2,897 | $9.01 | $26.1K | 213,087 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | S Sale | 2024-11-25 | 2024-11-27 | 2,948 | $9.01 | $26.6K | 269,059 | SEC↗ |
| Anderman Todd | Chief Legal Officer | A Award deriv | 2024-10-07 | 2024-10-09 | 296,500 | — | $0 | 296,500 | SEC↗ |
| Anderman Todd | Chief Legal Officer | A Award | 2024-10-07 | 2024-10-09 | 98,700 | — | $0 | 98,700 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | A Award deriv | 2024-10-02 | 2024-10-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Kaiser Peter | Chief Development Officer | A Award deriv | 2024-10-02 | 2024-10-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Heier Jeffrey S. | Chief Scientific Officer | A Award | 2024-10-02 | 2024-10-04 | 100,000 | — | $0 | 272,007 | SEC↗ |
| Kaiser Peter | Chief Development Officer | A Award | 2024-10-02 | 2024-10-04 | 100,000 | — | $0 | 215,984 | SEC↗ |
| Notman Donald | See Remarks | A Award deriv | 2024-08-29 | 2024-09-03 | 33,602 | — | $0 | 33,602 | SEC↗ |
| Notman Donald | See Remarks | A Award | 2024-08-29 | 2024-09-03 | 11,034 | — | $0 | 208,988 | SEC↗ |
| Dugel Pravin | See Remarks | S Sale | 2024-08-23 | 2024-08-27 | 20,880 | $9.02 | $188.3K | 812,473 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | S Sale | 2024-08-23 | 2024-08-27 | 1,832 | $9.02 | $16.5K | 176,194 | SEC↗ |
| Graves Adrienne L | Director | A Award deriv | 2024-07-24 | 2024-07-26 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Warden Charles M | Director | A Award deriv | 2024-07-24 | 2024-07-26 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Williams Leslie J. | Director | A Award deriv | 2024-07-24 | 2024-07-26 | 36,000 | — | $0 | 36,000 | SEC↗ |
| RAINES MERILEE | Director | A Award deriv | 2024-07-24 | 2024-07-26 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Hong Seung Suh | Director | A Award deriv | 2024-07-24 | 2024-07-26 | 36,000 | — | $0 | 36,000 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | A Award deriv | 2024-07-24 | 2024-07-26 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Graves Adrienne L | Director | A Award | 2024-07-24 | 2024-07-26 | 12,000 | — | $0 | 36,000 | SEC↗ |
| Warden Charles M | Director | A Award | 2024-07-24 | 2024-07-26 | 12,000 | — | $0 | 72,464 | SEC↗ |
| Williams Leslie J. | Director | A Award | 2024-07-24 | 2024-07-26 | 12,000 | — | $0 | 37,433 | SEC↗ |
| RAINES MERILEE | Director | A Award | 2024-07-24 | 2024-07-26 | 12,000 | — | $0 | 32,933 | SEC↗ |
| Hong Seung Suh | Director | A Award | 2024-07-24 | 2024-07-26 | 12,000 | — | $0 | 32,933 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | A Award | 2024-07-24 | 2024-07-26 | 12,000 | — | $0 | 162,704 | SEC↗ |
| Waheed Nadia | Chief Medical Officer | A Award deriv | 2024-06-01 | 2024-06-04 | 425,000 | — | $0 | 425,000 | SEC↗ |
| Waheed Nadia | Chief Medical Officer | A Award | 2024-06-01 | 2024-06-04 | 141,666 | — | $0 | 141,666 | SEC↗ |
| Dugel Pravin | See Remarks | S Sale | 2024-05-23 | 2024-05-28 | 21,626 | $5.79 | $125.2K | 833,353 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | S Sale | 2024-05-23 | 2024-05-28 | 2,274 | $5.84 | $13.3K | 178,026 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | M Exercise deriv | 2024-02-27 | 2024-07-26 | 18,939 | — | $0 | 0 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | M Exercise deriv | 2024-02-27 | 2024-07-26 | 11,363 | — | $0 | 0 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | M Exercise | 2024-02-27 | 2024-07-26 | 11,363 | $8.80 | $100.0K | 150,704 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | M Exercise | 2024-02-27 | 2024-07-26 | 18,939 | $8.80 | $166.7K | 139,341 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2024-02-26 | 2024-02-27 | 930,851 | $7.52 | $7.00M | 8,591,401 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | A Award deriv | 2024-02-22 | 2024-02-26 | 244,550 | — | $0 | 244,550 | SEC↗ |
| Dugel Pravin | Executive Chairman | A Award deriv | 2024-02-22 | 2024-02-26 | 1,282,469 | — | $0 | 1,282,469 | SEC↗ |
| Nayak Sanjay | Chief Strategy Officer | A Award | 2024-02-22 | 2024-02-26 | 80,300 | — | $0 | 180,300 | SEC↗ |
| Dugel Pravin | Executive Chairman | A Award | 2024-02-22 | 2024-02-26 | 854,979 | — | $0 | 854,979 | SEC↗ |
| Mattessich Antony C. | President and CEO | S Sale | 2024-02-05 | 2024-02-06 | 19,642 | $4.86 | $95.5K | 588,701 | SEC↗ |
| Notman Donald | Chief Financial Officer | S Sale | 2024-02-05 | 2024-02-06 | 6,212 | $4.86 | $30.2K | 195,356 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | S Sale | 2024-02-05 | 2024-02-06 | 6,346 | $4.86 | $30.8K | 153,054 | SEC↗ |
| Strassburger Philip C. | General Counsel | S Sale | 2024-02-05 | 2024-02-06 | 6,029 | $4.86 | $29.3K | 161,493 | SEC↗ |
| White Christopher G | Chief Business Officer | S Sale | 2024-02-05 | 2024-02-06 | 5,910 | $4.86 | $28.7K | 123,689 | SEC↗ |
| Mattessich Antony C. | President and CEO | A Award deriv | 2024-02-03 | 2024-02-06 | 549,400 | — | $0 | 549,400 | SEC↗ |
| Notman Donald | Chief Financial Officer | A Award deriv | 2024-02-03 | 2024-02-06 | 185,000 | — | $0 | 185,000 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award deriv | 2024-02-03 | 2024-02-06 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Strassburger Philip C. | General Counsel | A Award deriv | 2024-02-03 | 2024-02-06 | 175,000 | — | $0 | 175,000 | SEC↗ |
| White Christopher G | Chief Business Officer | A Award deriv | 2024-02-03 | 2024-02-06 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Mattessich Antony C. | President and CEO | A Award | 2024-02-03 | 2024-02-06 | 180,400 | — | $0 | 608,343 | SEC↗ |
| Notman Donald | Chief Financial Officer | A Award | 2024-02-03 | 2024-02-06 | 61,636 | — | $0 | 201,568 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award | 2024-02-03 | 2024-02-06 | 66,633 | — | $0 | 159,400 | SEC↗ |
| Strassburger Philip C. | General Counsel | A Award | 2024-02-03 | 2024-02-06 | 58,304 | — | $0 | 167,522 | SEC↗ |
| White Christopher G | Chief Business Officer | A Award | 2024-02-03 | 2024-02-06 | 39,980 | — | $0 | 129,599 | SEC↗ |
| Mattessich Antony C. | President and CEO | S Sale | 2024-01-31 | 2024-02-02 | 18,338 | $4.95 | $90.8K | 427,943 | SEC↗ |
| White Christopher G | Chief Business Officer | S Sale | 2024-01-31 | 2024-02-02 | 5,147 | $4.95 | $25.5K | 89,619 | SEC↗ |
| Strassburger Philip C. | General Counsel | S Sale | 2024-01-31 | 2024-02-02 | 6,831 | $4.95 | $33.8K | 109,218 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | S Sale | 2024-01-31 | 2024-02-02 | 7,764 | $4.95 | $38.4K | 92,767 | SEC↗ |
| Notman Donald | Chief Financial Officer | S Sale | 2024-01-31 | 2024-02-02 | 6,433 | $4.95 | $31.8K | 139,932 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2023-12-14 | 2023-12-18 | 1,538,461 | $3.25 | $5.00M | 7,660,550 | SEC↗ |
| Mattessich Antony C. | President and CEO | P Buy | 2023-08-30 | 2023-09-05 | 6,500 | $3.81 | $24.8K | 6,500 | SEC↗ |
| Heier Jeffrey S. | Director | A Award deriv | 2023-08-02 | 2023-08-18 | 17,350 | — | $0 | 17,350 | SEC↗ |
| Graves Adrienne L | Director | A Award deriv | 2023-07-10 | 2023-07-12 | 72,000 | — | $0 | 72,000 | SEC↗ |
| Graves Adrienne L | Director | A Award | 2023-07-10 | 2023-07-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | S Sale | 2023-07-07 | 2023-07-11 | 832 | $4.93 | $4.1K | 100,531 | SEC↗ |
| Heier Jeffrey S. | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Hong Seung Suh | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 36,000 | — | $0 | 36,000 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 36,000 | — | $0 | 36,000 | SEC↗ |
| RAINES MERILEE | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Williams Leslie J. | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Warden Charles M | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Heier Jeffrey S. | Director | A Award | 2023-06-14 | 2023-06-16 | 12,000 | — | $0 | 59,933 | SEC↗ |
| Hong Seung Suh | Director | A Award | 2023-06-14 | 2023-06-16 | 12,000 | — | $0 | 20,933 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | A Award | 2023-06-14 | 2023-06-16 | 12,000 | — | $0 | 120,402 | SEC↗ |
| RAINES MERILEE | Director | A Award | 2023-06-14 | 2023-06-16 | 12,000 | — | $0 | 20,933 | SEC↗ |
| Williams Leslie J. | Director | A Award | 2023-06-14 | 2023-06-16 | 12,000 | — | $0 | 25,433 | SEC↗ |
| Warden Charles M | Director | A Award | 2023-06-14 | 2023-06-16 | 12,000 | — | $0 | 60,464 | SEC↗ |
| Mattessich Antony C. | President and CEO | S Sale | 2023-02-06 | 2023-02-08 | 19,669 | $4.24 | $83.4K | 446,281 | SEC↗ |
| Strassburger Philip C. | General Counsel | S Sale | 2023-02-06 | 2023-02-08 | 6,181 | $4.24 | $26.2K | 109,071 | SEC↗ |
| Notman Donald | Chief Financial Officer | S Sale | 2023-02-06 | 2023-02-08 | 6,476 | $4.24 | $27.5K | 139,387 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | S Sale | 2023-02-06 | 2023-02-08 | 6,416 | $4.24 | $27.2K | 101,363 | SEC↗ |
| White Christopher G | Chief Business Officer | S Sale | 2023-02-06 | 2023-02-08 | 5,829 | $4.24 | $24.7K | 94,766 | SEC↗ |
| Mattessich Antony C. | President and CEO | A Award deriv | 2023-01-30 | 2023-02-01 | 536,900 | — | $0 | 536,900 | SEC↗ |
| Notman Donald | Chief Financial Officer | A Award deriv | 2023-01-30 | 2023-02-01 | 166,667 | — | $0 | 166,667 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award deriv | 2023-01-30 | 2023-02-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award deriv | 2023-01-30 | 2023-02-01 | 166,667 | — | $0 | 166,667 | SEC↗ |
| Strassburger Philip C. | General Counsel | A Award deriv | 2023-01-30 | 2023-02-01 | 166,667 | — | $0 | 166,667 | SEC↗ |
| White Christopher G | Chief Business Officer | A Award deriv | 2023-01-30 | 2023-02-01 | 133,333 | — | $0 | 133,333 | SEC↗ |
| Mattessich Antony C. | President and CEO | A Award | 2023-01-30 | 2023-02-01 | 176,300 | — | $0 | 465,950 | SEC↗ |
| Notman Donald | Chief Financial Officer | A Award | 2023-01-30 | 2023-02-01 | 55,556 | — | $0 | 145,863 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award | 2023-01-30 | 2023-02-01 | 55,556 | — | $0 | 107,779 | SEC↗ |
| Strassburger Philip C. | General Counsel | A Award | 2023-01-30 | 2023-02-01 | 55,556 | — | $0 | 115,252 | SEC↗ |
| White Christopher G | Chief Business Officer | A Award | 2023-01-30 | 2023-02-01 | 44,444 | — | $0 | 100,595 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-11-07 | 2022-11-09 | 7,328 | $3.50 | $25.6K | 6,122,089 | SEC↗ |
| Heier Jeffrey S. | Director | A Award deriv | 2022-10-17 | 2022-10-18 | 16,000 | — | $0 | 16,000 | SEC↗ |
| White Christopher G | Chief Business Officer | A Award deriv | 2022-10-13 | 2022-10-14 | 7,000 | — | $0 | 7,000 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-10-11 | 2022-10-12 | 10,000 | $3.90 | $39.0K | 6,114,761 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-10-10 | 2022-10-12 | 10,000 | $4.00 | $40.0K | 6,104,761 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-09-29 | 2022-09-29 | 18,800 | $4.04 | $76.0K | 6,094,761 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-09-28 | 2022-09-29 | 1,200 | $4.10 | $4.9K | 6,075,961 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-09-27 | 2022-09-29 | 130,000 | $4.68 | $608.4K | 6,074,761 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award deriv | 2022-07-14 | 2022-07-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award deriv | 2022-07-01 | 2022-07-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award deriv | 2022-07-01 | 2022-07-15 | 20,000 | — | $0 | 40,000 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award | 2022-07-01 | 2022-07-15 | 6,667 | — | $0 | 52,223 | SEC↗ |
| Heier Jeffrey S. | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 26,800 | — | $0 | 26,800 | SEC↗ |
| Hong Seung Suh | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 26,800 | — | $0 | 26,800 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 26,800 | — | $0 | 26,800 | SEC↗ |
| Warden Charles M | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 26,800 | — | $0 | 26,800 | SEC↗ |
| Williams Leslie J. | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 26,800 | — | $0 | 26,800 | SEC↗ |
| RAINES MERILEE | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 26,800 | — | $0 | 26,800 | SEC↗ |
| Heier Jeffrey S. | Director | A Award | 2022-06-16 | 2022-06-21 | 8,933 | — | $0 | 47,933 | SEC↗ |
| Hong Seung Suh | Director | A Award | 2022-06-16 | 2022-06-21 | 8,933 | — | $0 | 8,933 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | A Award | 2022-06-16 | 2022-06-21 | 8,933 | — | $0 | 108,402 | SEC↗ |
| Warden Charles M | Director | A Award | 2022-06-16 | 2022-06-21 | 8,933 | — | $0 | 48,464 | SEC↗ |
| Williams Leslie J. | Director | A Award | 2022-06-16 | 2022-06-21 | 8,933 | — | $0 | 13,433 | SEC↗ |
| RAINES MERILEE | Director | A Award | 2022-06-16 | 2022-06-21 | 8,933 | — | $0 | 8,933 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | M Exercise deriv | 2022-05-12 | 2022-05-16 | 9,469 | — | $0 | 0 | SEC↗ |
| Heier Jeffrey S. | Director | P Buy | 2022-05-12 | 2022-05-16 | 15,000 | $3.05 | $45.8K | 39,000 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | M Exercise | 2022-05-12 | 2022-05-16 | 9,469 | $1.22 | $11.6K | 99,469 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-02-23 | 2022-02-23 | 10,000 | $4.80 | $48.0K | 5,944,761 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-02-18 | 2022-02-23 | 40,000 | $5.00 | $200.0K | 5,934,761 | SEC↗ |
| Mattessich Antony C. | President and CEO | A Award deriv | 2022-02-03 | 2022-02-07 | 560,200 | — | $0 | 560,200 | SEC↗ |
| Goldstein Michael H. | President, Ophthalmology & C | A Award deriv | 2022-02-03 | 2022-02-07 | 190,000 | — | $0 | 190,000 | SEC↗ |
| White Christopher G | Chief Business Officer | A Award deriv | 2022-02-03 | 2022-02-07 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Strassburger Philip C. | General Counsel | A Award deriv | 2022-02-03 | 2022-02-07 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Notman Donald | Chief Financial Officer | A Award deriv | 2022-02-03 | 2022-02-07 | 166,667 | — | $0 | 166,667 | SEC↗ |
| Mattessich Antony C. | President and CEO | A Award | 2022-02-03 | 2022-02-07 | 186,750 | — | $0 | 289,650 | SEC↗ |
| Goldstein Michael H. | President, Ophthalmology & C | A Award | 2022-02-03 | 2022-02-07 | 63,333 | — | $0 | 313,335 | SEC↗ |
| White Christopher G | Chief Business Officer | A Award | 2022-02-03 | 2022-02-07 | 50,000 | — | $0 | 52,127 | SEC↗ |
| Strassburger Philip C. | General Counsel | A Award | 2022-02-03 | 2022-02-07 | 50,000 | — | $0 | 51,810 | SEC↗ |
| Notman Donald | Chief Financial Officer | A Award | 2022-02-03 | 2022-02-07 | 55,556 | — | $0 | 81,632 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-01-28 | 2022-01-31 | 4,023 | $5.20 | $20.9K | 5,894,761 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-01-27 | 2022-01-31 | 1,477 | $5.20 | $7.7K | 5,890,738 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-01-24 | 2022-01-24 | 44,400 | $5.31 | $235.8K | 5,889,261 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-01-21 | 2022-01-24 | 12,152 | $5.56 | $67.6K | 5,844,861 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-01-20 | 2022-01-24 | 17,948 | $5.70 | $102.3K | 5,832,709 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-01-18 | 2022-01-18 | 6,807 | $6.00 | $40.8K | 5,814,761 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-01-14 | 2022-01-18 | 33,193 | $6.03 | $200.2K | 5,807,954 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2022-01-13 | 2022-01-18 | 10,000 | $6.20 | $62.0K | 5,774,761 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2021-12-15 | 2021-12-16 | 15,000 | $6.22 | $93.3K | 5,764,761 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2021-12-14 | 2021-12-16 | 29,490 | $6.41 | $189.0K | 5,749,761 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2021-12-13 | 2021-12-14 | 10,510 | $6.50 | $68.3K | 5,720,271 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2021-12-10 | 2021-12-14 | 30,000 | $6.65 | $199.5K | 5,709,761 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2021-12-08 | 2021-12-08 | 5,300 | $6.75 | $35.8K | 5,679,761 | SEC↗ |
| SUMMER ROAD LLC | 10% Owner | P Buy | 2021-12-06 | 2021-12-08 | 55,600 | $6.13 | $340.8K | 5,674,461 | SEC↗ |
| White Christopher G | Chief Business Officer | A Award deriv | 2021-10-01 | 2021-10-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RAINES MERILEE | Director | A Award deriv | 2021-09-20 | 2021-09-22 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Mattessich Antony C. | President and CEO | P Buy | 2021-08-20 | 2021-08-24 | 5,000 | $9.89 | $49.5K | 102,900 | SEC↗ |
| Heier Jeffrey S. | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Hong Seung Suh | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| PEACOCK BRUCE | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Warden Charles M | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Williams Leslie J. | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | S Sale | 2021-05-20 | 2021-05-21 | 10,000 | $14.30 | $143.0K | 90,000 | SEC↗ |
| Strassburger Philip C. | General Counsel | A Award deriv | 2021-02-17 | 2021-02-19 | 51,900 | — | $0 | 51,900 | SEC↗ |
| Notman Donald | Chief Financial Officer | A Award deriv | 2021-02-17 | 2021-02-19 | 190,000 | — | $0 | 190,000 | SEC↗ |
| Mattessich Antony C. | President and CEO | A Award deriv | 2021-02-17 | 2021-02-19 | 455,000 | — | $0 | 455,000 | SEC↗ |
| Kitchen Patricia | Chief Operating Officer | A Award deriv | 2021-02-17 | 2021-02-19 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Goldstein Michael H. | President, Ophthalmology & C | A Award deriv | 2021-02-17 | 2021-02-19 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Warden Charles M | Director | J Other | 2021-02-15 | 2021-02-17 | 35,912 | — | $0 | 39,531 | SEC↗ |
| Warden Charles M | Director | J Other | 2021-02-15 | 2021-02-17 | 8,604 | — | $0 | 0 | SEC↗ |
| Warden Charles M | Director | J Other | 2021-02-15 | 2021-02-17 | 1,456,780 | — | $0 | 0 | SEC↗ |
| Warden Charles M | Director | J Other | 2021-02-15 | 2021-02-17 | 375,121 | — | $0 | 375,121 | SEC↗ |
| Warden Charles M | Director | J Other | 2021-02-15 | 2021-02-17 | 375,121 | — | $0 | 0 | SEC↗ |
| Warden Charles M | Director | J Other | 2020-12-04 | 2020-12-08 | 37,208 | — | $0 | 0 | SEC↗ |
| Warden Charles M | Director | J Other | 2020-12-04 | 2020-12-08 | 3,619 | — | $0 | 3,619 | SEC↗ |
| Warden Charles M | Director | J Other | 2020-12-04 | 2020-12-08 | 4,403 | — | $0 | 8,604 | SEC↗ |
| Warden Charles M | Director | J Other | 2020-12-04 | 2020-12-08 | 37,208 | — | $0 | 37,208 | SEC↗ |
| Warden Charles M | Director | J Other | 2020-12-04 | 2020-12-08 | 745,597 | — | $0 | 1,456,780 | SEC↗ |
| PEACOCK BRUCE | Director | M Exercise deriv | 2020-12-03 | 2020-12-07 | 7,000 | — | $0 | 11,000 | SEC↗ |